n-methyl-3,4-methylenedioxyamphetamine has been researched along with Fatty Liver in 1 studies
N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.
Fatty Liver: Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS.
Excerpt | Relevance | Reference |
---|---|---|
" Pathohistology revealed microvascular steatosis in the liver, which raised the possibility of chronic use of toxic substances." | 1.38 | [A new designer drug: methylone related death]. ( Kereszty, EM; Kovács, K; Tóth, AR, 2012) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kovács, K | 1 |
Tóth, AR | 1 |
Kereszty, EM | 1 |
1 other study available for n-methyl-3,4-methylenedioxyamphetamine and Fatty Liver
Article | Year |
---|---|
[A new designer drug: methylone related death].
Topics: Adolescent; Amphetamine; Asthma; Autopsy; Causality; Death, Sudden, Cardiac; Designer Drugs; Drug Ov | 2012 |